Corrigendum: ACTIVATE-2: A double-blind randomized trial of BCG vaccination against COVID-19 in individuals at risk.

Authors :: Tsilika M
Taks E
Dolianitis K
Kotsaki A
Leventogiannis K
Damoulari C
Kostoula M
Paneta M
Adamis G
Papanikolaou I
Stamatelopoulos K
Bolanou A
Katsaros K
Delavinia C
Perdios I
Pandi A
Tsiakos K
Proios N
Kalogianni E
Delis I
Skliros E
Akinosoglou K
Perdikouli A
Poulakou G
Milionis H
Athanassopoulou E
Kalpaki E
Efstratiou L
Perraki V
Papadopoulos A
Netea MG
Giamarellos-Bourboulis EJ
Source :: Frontiers in immunology [Front Immunol] 2022 Aug 31; Vol. 13, pp. 1018384. Date of Electronic Publication: 2022 Aug 31 (Print Publication: 2022).
Publication Year :: 2022
Abstract: [This corrects the article DOI: 10.3389/fimmu.2022.873067.].<br /> (Copyright © 2022 Tsilika, Taks, Dolianitis, Kotsaki, Leventogiannis, Damoulari, Kostoula, Paneta, Adamis, Papanikolaou, Stamatelopoulos, Bolanou, Katsaros, Delavinia, Perdios, Pandi, Tsiakos, Proios, Kalogianni, Delis, Skliros, Akinosoglou, Perdikouli, Poulakou, Milionis, Athanassopoulou, Kalpaki, Efstratiou, Perraki, Papadopoulos, Netea and Giamarellos-Bourboulis.)

Full Text Access

Tools